Devonian Health Group Inc.
GSD.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.29M | 6.68M | 3.78M | 1.69M | 937.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.29M | 6.68M | 3.78M | 1.69M | 937.10K |
| Cost of Revenue | 3.04M | 4.16M | 2.85M | 1.11M | 557.10K |
| Gross Profit | 1.25M | 2.52M | 922.60K | 574.10K | 380.00K |
| SG&A Expenses | 1.10M | 1.37M | 894.80K | 1.17M | 558.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 23.20K | 21.80K | 22.00K | 22.90K | 22.90K |
| Total Operating Expenses | 4.52M | 5.79M | 3.99M | 2.53M | 1.41M |
| Operating Income | -237.40K | 883.60K | -209.80K | -846.50K | -471.80K |
| Income Before Tax | -264.90K | 789.40K | -275.50K | -896.40K | -531.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -264.90K | 789.40K | -275.50K | -896.40K | -531.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -264.90K | 789.40K | -275.50K | -896.40K | -531.30K |
| EBIT | -237.40K | 883.60K | -209.80K | -846.50K | -471.80K |
| EBITDA | -172.10K | 1.12M | -131.20K | -767.30K | -393.40K |
| EPS Basic | 0.00 | 0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 148.22M | 148.23M | 146.73M | 146.35M | 145.96M |
| Average Diluted Shares Outstanding | 148.22M | 148.23M | 146.73M | 146.35M | 145.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
